Search Results - A. Tefferi
- Showing 1 - 4 results of 4
-
1
P775: CLINICAL OUTCOMES AND SOCIOECONOMIC FACTORS IN CHRONIC MYELOMONOCYTIC LEUKEMIA IN THE UNITED STATES USING THE NATIONAL CANCER DATABASE: 2004-2017 by N. Mclaughlin, G. Ruan, K. Wudhikarn, A. Al-Kali, A. Tefferi, N. Gangat, R. Go, M. Patnaik, M. Shah
Published in HemaSphere (2022-06-01)Get full text
Article -
2
P544: MOLECULAR PREDICTORS OF RESPONSE AND SURVIVAL IN TREATMENT-NAÏVE PATIENTS WITH ACUTE MYELOID LEUKEMIA FOLLOWING VENETOCLAX AND HYPOMETHYLATING AGENTS by I. Johnson, K. McCullough, F. Farrukh, A. Al-Kali, H. Alkhateeb, K. Begna, A. Mangaonkar, M. Litzow, W. Hogan, M. Shah, M. Patnaik, A. Pardanani, A. Tefferi, N. Gangat
Published in HemaSphere (2022-06-01)Get full text
Article -
3
P1041: IMPACT OF FEDRATINIB ON SPLEEN VOLUME AND MYELOFIBROSIS SYMPTOMS IN PATIENTS WITH SUBSTANTIAL SPLENOMEGALY: POST HOC ANALYSES FROM THE JAKARTA AND JAKARTA2 TRIALS by J.-J. Kiladjian, A. Tefferi, F. Passamonti, A. Vannucchi, M. Talpaz, F. Cervantes, C. N. Harrison, R. A. Mesa, J. Mascarenhas, N. Schaap, S. Verstovsek, T. Devos, S. Rose, J. Zhang, O. Sy, A. Pardanani
Published in HemaSphere (2022-06-01)Get full text
Article -
4
Core-binding factor acute myeloid leukemia: long-term outcome of 70 patients uniformly treated with “7+3” by K. H. Begna, X. Xu, N. Gangat, H. Alkhateeb, M. M. Patnaik, A. Al-Kali, M. A. Elliott, W. J. Hogan, M. R. Litzow, C. C. Hook, A. P. Wolanskyj-Spinner, A. Mangaonkar, R. He, A. Pardanani, M. Shah, R. P. Ketterling, A. Tefferi
Published in Blood Cancer Journal (2022-04-01)Get full text
Article
